Serum Levels of G-CSF and IL-7 in Iranian Breast Cancer Patients |
Bordbar, Elahe
(Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences)
Malekzadeh, Mahyar (Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences) Ardekani, Mehdi Taghipour Fard (Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences) Doroudchi, Mehrnoosh (Department of Immunology, School of Medicine, Shiraz University of Medical Sciences) Ghaderi, Abbas (Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences) |
1 | Jicha DL, Mulé JJ, Rosenberg SA (1991). Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy. J Exp Med, 174, 1511-5. DOI |
2 | Kaminski MJ, Cruz PD JR, Bergstresser PR, Takashima A (1993). Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells. Cancer Res, 53, 4014-9. |
3 | Kowanetz M, Wu X, Lee J, et al (2010). Granulocytecolony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc Natl Acad Sci USA, 107, 21248-55. DOI |
4 | Kim GY, Hong C, Park JH (2011). Seeing is believing, illuminating the source of in vivo interleukin-7. Immune Netw, 11, 1-10. DOI |
5 | Love-Schimenti CD, Kripke ML (1994). Dendritic epidermal T cells inhibit T cell proliferation and may induce tolerance by cytotoxicity. J Immunol, 153, 3450-6. |
6 | Lawicki S, Czygier M, Gacuta-Szumarska E, et al (2006).The plasma levels and diagnostic utility of granulocyte colony stimulating factor (G-CSF) and macrophage - colony stimulating factor (M-CSF) in ovarian cancer patients. Pol Merkur Lekarski, 21, 465-8. |
7 | Lawicki S, Czygier M, Wojtukiewicz M, et al (2009). The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer. Przegl Lek, 66, 365-9. |
8 | Matsue H, Bergstresser PR, Takashima A (1993). Keratinocyte-derived IL-7 serves as a growth factor for dendritic epidermal T cells in mice. J Immunol, 151, 6012-9. |
9 | Maeurer MJ, Walter W, Martin D, et al (1997). Interleukin-7 (IL-7) in colorectal cancer, IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes. Scand J Immunol, 45, 182-92. DOI |
10 | Mroczko B, Szmitkowski M, Niklinski J (2001). Granulocyte-Colony stimulating factor and macrophage-colony stimulating factor in patients with non-small-cell lung cancer. Clin Chem Lab Med, 39, 374-9. |
11 | Mroczko B, Szmitkowski M, Okulczyk B (2002). Granulocyte-colony stimulating factor (G-CSF) and macrophagecolony stimulating factor (M-CSF) in colorectal cancer patients. Clin Chem Lab Med, 40, 351-5. |
12 | Montazeri A, Vahdaninia M, Harirchi I, et al (2008). Breast cancer in Iran, need for greater women awareness of warning signs and effective screening methods. Asia Pac Fam Med, 7, 6. DOI ScienceOn |
13 | Matsumoto Y, Mabuchi S, Muraji M, Morii E, Kimura T (2010). Squamous cell carcinoma of the uterine cervix producing granulocyte colony-stimulating factor, a report of 4 cases and a review of the literature. Int J Gynecol Cancer, 20, 417-21. DOI |
14 | Nishimura K, Higashino M, Hara T, (1996). Bladder cancer producing granulocyte colony-stimulating factor, a case report. Int J Urol, 3, 152-4. DOI |
15 | Natori T, Sata M, Washida M, et al (2002). G-CSF stimulates angiogenesis and promotes tumor growth, potential contribution of bone marrow-derived endothelial progenitor cells. Biochem Biophys Res Commun, 297, 1058-61. DOI |
16 | Nasu K, Inoue C, Takai N, Kashima K, Miyakawa I (2004). Squamous cell carcinoma of the cervix producing granulocyte colony-stimulating factor. Obstet Gynecol, 104, 1086-8. DOI |
17 | Shojaei F, Wu X, Qu X, et al (2009). G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models. Proc Natl Acad Sci USA, 106, 6742-7. DOI |
18 | Pentheroudakis G, Malamou-Mitsi V, Briasoulis E, et al (2004). The neutrophil, not the tumor, serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy. Cancer, 101, 1767-75. DOI |
19 | Roato I, Brunetti G, Gorassini E, et al (2006). IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor. PLoS One, 1, 124. DOI |
20 | Ravishankaran P, Karunanithi R (2011). Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients. World J Surg Oncol, 9, 18. DOI ScienceOn |
21 | Sabatier R, Jacquemier J, Bertucci F, et al (2011). Peritumoural vascular invasion, a major determinant of triple-negative breast cancer outcome. Eur J Cancer, 47, 1537-45. DOI |
22 | Takashima A, Matsue H, Bergstresser Pr, et al (1995). Interleukin-7-dependent interaction of dendritic epidermal T cells with keratinocytes. J Invest Dermatol, 105, 50-3. DOI |
23 | Taylor-Papadimitriou J, Burchell J, Miles DW, Dalziel M (1999). MUC1 and cancer. Acta Biochim Biophys, 1455, 301-13. DOI |
24 | Taghavi A, Fazeli Z, Vahedi M, et al (2012). Increased trend of breast cancer mortality in Iran. Asian Pac J Cancer Prev, 13, 367-70. 과학기술학회마을 DOI ScienceOn |
25 | Czygier M, Ławicki S, Gacuta-Szumarska E, Bedkowska E, Szmitkowski M (2010). The plasma level of sL-selectin, myeloperoxidase (MPO) and granulocyte-colony stimulating factor (G-CSF) in gynecological cancer patients. Przegl Lek, 67, 184-6. |
26 | Waight JD, Hu Q, Miller A, Liu S, Abrams SI (2011). Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS One, 6, 27690. DOI |
27 | Yamano T, Morii E, Ikeda J, et al (2007). Granulocyte colonystimulating factor production and rapid progression of gastric cancer after histological change in the tumor. Jpn J Clin Oncol, 37, 793-6. DOI |
28 | Asano T, Morimoto S, Kitami Y, et al (2002). Bladder cancer producing granulocyte colony-stimulating factor (G-CSF): a case report. Hinyokika Kiyo, 48, 495-8. |
29 | Al-Rawi MA, Rmali K, Watkins G, et al (2004). Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer. Eur J Cancer, 40, 494-502. DOI |
30 | Andersson A, Srivastava MK, Harris-White M, et al (2011). Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer. Clin Cancer Res, 17, 3660-72. DOI |
31 | Cavanagh LL, Halliday GM (1996). Dendritic epidermal T cells in ultraviolet-irradiated skin enhance skin tumor growth by inhibiting CD4+ T-cell-mediated immunity. Cancer Res, 56, 2607-15. |
32 | Chavey C, Bibeau F, Gourgou-Bourgade S, et al (2007). Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res, 9, 15. |
33 | Dehqanzada ZA, Storrer CE, Hueman MT, et al (2007). Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology. Oncol Rep, 17, 687-94. |
34 | Franchina T, Adamo B, Ricciardi GP, et al (2012). Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement, Two case reports. Cancer Biol Ther, 13, 472-6. DOI |
35 | Heufler C, Topar G, Grasseger A, et al (1993). Interleukin 7 is produced by murine and human keratinocytes. J Exp Med, 178, 1109-14. DOI |
36 | Ikeda T, Ohgaki K, Miura M, et al (2005). Granulocyte-colony stimulating factor-producing gallbladder cancer without recurrence more than 2 years after resection, report of a case. Surg Today, 35, 590-3. DOI |